BIOMARIN PHARMACEUTICAL INC(NASDAQ:BMRN) stock News

BMRN Latest News, Press Relases and Analysis

All

Press Releases

a day ago - By: Zacks Investment Research - Mentions: GILD

Gilead Sciences (GILD) Earnings Expected to Grow: Should You Buy?

2 days ago - By: BioMarin Pharmaceutical Inc.

BioMarin to Host Third Quarter 2025 Financial Results Conference Call and Webcast on Monday, October 27, 2025, at 4:30pm ET

15 days ago - By: Benzinga

Is BioMarin Pharmaceutical Inc Gaining or Losing Market Support?

15 days ago - By: Benzinga

6 Analysts Assess BioMarin Pharmaceutical: What You Need To Know

23 days ago - By: Zacks Investment Research

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock

a month ago - By: Zacks Investment Research

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock

2 months ago - By: Zacks Investment Research

Are Options Traders Betting on a Big Move in BioMarin Pharmaceutical Stock?

2 months ago - By: BioMarin Pharmaceutical Inc.

BioMarin Shares New Data Reinforcing Its Leadership in Bone Health at the American Society for Bone and Mineral Research Annual Meeting

2 months ago - By: BioMarin Pharmaceutical Inc.

BioMarin Announces Positive Pivotal Phase 3 Data for PALYNZIQ® (pegvaliase-pqpz) in Adolescents with Phenylketonuria at 15th International Congress of Inborn Errors of Metabolism

2 months ago - By: Zacks Investment Research - Mentions: GSK

BioMarin (BMRN) Down 4.6% Since Last Earnings Report: Can It Rebound?

2 months ago - By: Zacks Investment Research

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock

2 months ago - By: Yahoo Finance

Bernstein Maintains a Buy Rating on BioMarin Pharmaceutical (BMRN)

2 months ago - By: The Motley Fool - Mentions: TSLA META MSFT SBUX ...

Predicting the Next Rule Breaker Buyout

2 months ago - By: Zacks Investment Research

BioMarin Pharmaceutical (BMRN) is a Top-Ranked Momentum Stock: Should You Buy?

2 months ago - By: Zacks Investment Research

BIOMARIN PHARMACEUTICAL INC (BMRN) Stock News

BMRN Latest News, Press Relases and Analysis

Gilead Sciences (GILD) Earnings Expected to Grow: Should You Buy?

BioMarin to Host Third Quarter 2025 Financial Results Conference Call and Webcast on Monday, October 27, 2025, at 4:30pm ET

Is BioMarin Pharmaceutical Inc Gaining or Losing Market Support?

6 Analysts Assess BioMarin Pharmaceutical: What You Need To Know

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock

Are Options Traders Betting on a Big Move in BioMarin Pharmaceutical Stock?

BioMarin Shares New Data Reinforcing Its Leadership in Bone Health at the American Society for Bone and Mineral Research Annual Meeting

BioMarin Announces Positive Pivotal Phase 3 Data for PALYNZIQ® (pegvaliase-pqpz) in Adolescents with Phenylketonuria at 15th International Congress of Inborn Errors of Metabolism

BioMarin (BMRN) Down 4.6% Since Last Earnings Report: Can It Rebound?

Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock

Bernstein Maintains a Buy Rating on BioMarin Pharmaceutical (BMRN)

Predicting the Next Rule Breaker Buyout

BioMarin Pharmaceutical (BMRN) is a Top-Ranked Momentum Stock: Should You Buy?

Why BioMarin Pharmaceutical (BMRN) is a Top Value Stock for the Long-Term